BASF talks novel excipients
18-Nov-2009 - The FDA encourages innovation in excipients to develop new drugs or improve approved therapeutics and...
Colorcon rolls out On-Dose ID anti-counterfeiting tech
17-Nov-2009 - Colorcon has met US FDA calls for PCIDs to combat fake drugs with the mark...
Cafosa launches gum delivery excipient
17-Nov-2009 - Spanish ingredient supplier Cafosa has launched a new directly compressible pharmaceutical excipient for medicated chewing...
API quality enforcement in disarray; Villax
17-Nov-2009 - Regulatory enforcement efforts to tackle counterfeit and substandard APIs are in disarray, according to Guy...
News in brief
ISP launches excipient website
12-Nov-2009 - ISP Pharmaceuticals hopes its new excipient focussed web resource will help the drug industry formulate...
Galenix and DSM sign manufacturing and marketing accord
12-Nov-2009 - French drug delivery specialist Galenix has named DSM’s pharmaceutical products unit as its manufacturing and...
Six Pfizer-Wyeth R&D sites to close post merger
10-Nov-2009 - Pfizer will close six R&D facilities in the US and the UK, reducing its global...
BASF’s Kollicoat of many colours
09-Nov-2009 - BASF says the new coloured tablet extension to its Kollicoat IR coating polymer will help...
News in brief
USP revised glycol and sorbitol monographs published.
09-Nov-2009 - New US Pharmacopeial Convention (USP) monographs designed to prevent adulteration of key excipients with diethylene...
Catalent unveils ulta-sensitive melamine test for drugs
05-Nov-2009 - US contract services firm Catalent has launched a new test service capable of detecting trace...
Novartis invests in China
03-Nov-2009 - Novartis is investing $250m (€170m) to construct a facility in China focused on research, development...
Lonza cuts 2009 guidance 14% and plans workforce cuts
02-Nov-2009 - Lonza cuts 2009 earning guidance and may reduce its workforce under “Project Bond” cost cutting...
News in brief
Phoenix helps closed Shasun plant rise from the “ashes”
02-Nov-2009 - Phoenix Chemicals will re-open a chemicals manufacturing plant in Scotland less than a year after...
CDC targets track and trace
28-Oct-2009 - CDC Software has launched Trace Express Viewer which helps identify suspect materials, provides cGxP compliant...
Hovione adds aseptic spray drying to offering
26-Oct-2009 - Portuguese CMO Hovione has bought an aseptic spray-drying line from US firm Acusphere and says...
Soluplus launched as market for HME excipients heats up
22-Oct-2009 - BASF says its new Soluplus excipient will help meet demand for solubilising agents that are...
FDA buys fake Tamiflu to warn consumers
21-Oct-2009 - The FDA has warned consumers about the spread of counterfeit H1N1 treatments after the agency...
APC’s new R&D unit to focus on complex peptides
21-Oct-2009 - The American Peptide Company (APC) plans to set up an R&D unit at its facility...
Lonza withdraws Patheon bid, but still keen on CMOs
20-Oct-2009 - Swiss healthcare services giant Lonza has withdrawn its offer for Canadian CMO Patheon, citing value...
H Lundbeck eschews outsourcing and buys Elaiapharm
20-Oct-2009 - CNS focused drugmaker H Lundbeck says its acquisition of French CMO Elaiapharm represents a cheaper...
EC GMP directive “still alive”; Cargill
19-Oct-2009 - The EC’s plan to make excipients comply with GMP is “still alive”, according to Cargill...
Arch adds first plant scale SMB in India
19-Oct-2009 - Arch Pharmalabs is continuing its push to serve innovative pharma by adding simulated moving bed...
CPhI 2009 - Road to recovery?
15-Oct-2009 - As CPhI 2009 draws to a close we take a look back on the show,...
News in brief
Lilly sells Tippecanoe API site to Evonik
15-Oct-2009 - US drugmaker Eli Lilly will sell its Tippecanoe laboratories API manufacturing unit to Germany’s Evonik...
galenIQ 981 cuts coating time and extends shelf-life, says Beneo Palatinit
14-Oct-2009 - Beneo-Palatinit’s new galenIQ 981 excipient offers drugmakers a way of improving industrial processing, stability and...
